Dore, David D <br/><br/>
Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.  [electronic resource] 

 -  Pharmacoepidemiology and drug safety  May 2012 
 - 29-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1557 
<br/><br/><label>Standard No.: </label>10.1002/pds.3244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Aromatase Inhibitors--administration & dosage<br/>Breast Neoplasms--diagnosis<br/>Cohort Studies<br/>Confounding Factors, Epidemiologic<br/>Databases, Factual--statistics & numerical data<br/>Female<br/>Humans<br/>Insurance Claim Review--statistics & numerical data<br/>Medical Record Linkage<br/>Pharmacoepidemiology--methods<br/>Proportional Hazards Models<br/>Tamoxifen--administration & dosage<br/>United States